Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Clinical trial NCT06014658 · RECRUITING
Trial details
- NCT number
- NCT06014658
- Sponsor
- MBrace Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2026-07-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.